BioStem Technologies

Develops and manufactures placental (perinatal) tissue allografts for regenerative therapies using a proprietary processing method that preserves growth factors and tissue structure. Products are produced under AATB-accredited, cGTP/cGMP-compliant quality management and standard operating procedures for medical use.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading